Lv31
380 积分 2024-11-02 加入
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
5小时前
求助中
Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab Response
23天前
已完结
Delays in the surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: A population-based analysis
4个月前
已完结
The effect of surgical timing in nonmetastatic melanoma
4个月前
已完结
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma
4个月前
已完结
Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study
4个月前
已完结
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
4个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
5个月前
已完结
Nonoperative Management of Mismatch Repair–Deficient Tumors
5个月前
已完结
Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL)
5个月前
已完结
皖公网安备34019202002308
